Cough, Cold and Allergy (Hay Fever) Remedies in Uzbekistan

PROSPECTS

Growth in number of allergy sufferers

According to the Chief Allergist of the Ministry of Health of the Republic of Uzbekistan, even 15 years ago only 5-10% of the population suffered from allergies. Today, due to the impact of a variety of factors, this percentage has increased significantly.

Cough remedies are mostly consumed in winter, especially among children

While demand for allergy remedies increases in late spring, cough remedies are mainly consumed during winter. Winters are cold in Uzbekistan, and thus, the majority of people – especially children – catch colds during the colder winter months.

New launches set to boost cough, cold and allergy (hay fever) remedies

Due to new regulations, many changes are expected in the pharmaceutical industry. Some brands will likely leave the category while new ones will make an entrance.

COMPETITIVE LANDSCAPE

Multinationals, led by Nycomed, characterise category sales

Nycomed Pharma held the leading position in cough, cold and allergy (hay fever) remedies in 2018. The company benefited from its longstanding presence in the country’s consumer health market and from the popularity of its Nasivin brand in both spray and drops.

Fervex by Bristol-Myers outperforms GSK’s Coldrex largely due to its lower cost

After its acquisition of Novartis’s consumer health portfolio, GSK Consumer Healthcare strengthened its position in cough, cold and allergy (hay fever) remedies. GSK’s Coldrex, Tavegil and Dlyanos brands elevated the company into third place in 2018.

Uzbekistani producers remain weak

Unlike other OTC categories, where Uzbekistani producers have increased their value shares by squeezing out foreign competitors, the situation in cough, cold and allergy (hay fever) remedies was very different in 2018. Uzbekistani pharmaceutical companies are very weak in the category.

Files are delivered directly into your account within a few minutes of purchase.